Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bum Jun Kim

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
Oncotarget|November 2, 2017
Clinicopathological impacts of high c-Met expression in renal cell carcinoma: a meta-analysis and reviewJung Han Kim, Bum Jun Kim, Hyeong Su Kim
Oncotarget|November 2, 2017
MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and reviewJung Han Kim, Hyeong Su Kim, Bum Jun Kim
Medicine|October 1, 2021
Bilateral retinal pigment epithelial tears in acute central serous chorioretinopathy without bullous retinal detachment: A case reportWoo Hyuk Lee, Bum Jun Kim, Yong Seop Han
The Science of the Total Environment|October 17, 2024
Influence of Pseudomonas aeruginosa-based biopolymer on mitigating soil erosion and heavy metal dispersionBum-Jun Kim, Yong-Jung Jeon, Myoung-Soo Ko
Oncotarget|September 9, 2017
Survival benefit of immune checkpoint inhibitors according to the histology in non-small-cell lung cancer: A meta-analysis and reviewBum Jun Kim, Jung Han Kim, Hyeong Su Kim
Oncotarget|December 2, 2017
Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysisJung Han Kim, Hyeong Su Kim, Bum Jun Kim
Oncotarget|December 20, 2017
Molecular targeted agents as second-line treatment for hepatocellular carcinoma: a meta-analysis and reviewJung Han Kim, Bum Jun Kim, Hyun Joo Jang, et al.
Oncotarget|October 27, 2017
The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta-analysis of randomized trialsHyun Joo Jang, Bum Jun Kim, Jung Han Kim, et al.
Oncotarget|January 20, 2017
Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and reviewBum Jun Kim, Jung Han Kim, Hyeong Su Kim, et al.
Cancer Chemotherapy and Pharmacology|August 7, 2017
Comparison of the RECIST and EORTC PET criteria in the tumor response assessment: a pooled analysis and reviewJung Han Kim, Bum Jun Kim, Hyun Joo Jang, et al.
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
Oncotarget|November 2, 2017
Clinicopathological impacts of high c-Met expression in renal cell carcinoma: a meta-analysis and reviewJung Han Kim, Bum Jun Kim, Hyeong Su Kim
Oncotarget|November 2, 2017
MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and reviewJung Han Kim, Hyeong Su Kim, Bum Jun Kim
Medicine|October 1, 2021
Bilateral retinal pigment epithelial tears in acute central serous chorioretinopathy without bullous retinal detachment: A case reportWoo Hyuk Lee, Bum Jun Kim, Yong Seop Han
The Science of the Total Environment|October 17, 2024
Influence of Pseudomonas aeruginosa-based biopolymer on mitigating soil erosion and heavy metal dispersionBum-Jun Kim, Yong-Jung Jeon, Myoung-Soo Ko
Oncotarget|September 9, 2017
Survival benefit of immune checkpoint inhibitors according to the histology in non-small-cell lung cancer: A meta-analysis and reviewBum Jun Kim, Jung Han Kim, Hyeong Su Kim
Oncotarget|December 2, 2017
Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysisJung Han Kim, Hyeong Su Kim, Bum Jun Kim
Oncotarget|December 20, 2017
Molecular targeted agents as second-line treatment for hepatocellular carcinoma: a meta-analysis and reviewJung Han Kim, Bum Jun Kim, Hyun Joo Jang, et al.
Oncotarget|October 27, 2017
The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta-analysis of randomized trialsHyun Joo Jang, Bum Jun Kim, Jung Han Kim, et al.
Oncotarget|January 20, 2017
Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and reviewBum Jun Kim, Jung Han Kim, Hyeong Su Kim, et al.
Cancer Chemotherapy and Pharmacology|August 7, 2017
Comparison of the RECIST and EORTC PET criteria in the tumor response assessment: a pooled analysis and reviewJung Han Kim, Bum Jun Kim, Hyun Joo Jang, et al.
Pageof 13